The Straight Version
A clinical trial for Pfizer's lung cancer drug sigvotatug vedotin failed to show a significant increase in survival rates compared to standard therapy.
The UNHINGED Take
Pfizer's BIG PHARMA HYPE TRAIN just got DERAILED by their own failed trial - sigvotatug vedotin couldn't even beat standard therapy, WHAT A JOKE. Patients and families were likely HANGING ON TO HOPE, only to be let down by this OVERHYPED DRUG. Time to GO BACK TO THE DRAWING BOARD, Pfizer!
The Bottom Line
FAILED EXPERIMENT / 10
Pfizer's BIG PHARMA HYPE TRAIN just got DERAILED by their own failed trial - sigvotatug vedotin couldn't even beat standard therapy, WHAT A JOKE.
📣 Copy, Paste, Cause Chaos
Pfizer's BIG PHARMA HYPE TRAIN just got DERAILED by their own failed trial - sigvotatug vedotin couldn't even beat standard therapy, WHAT A JOKE. FAILED EXPERIMENT / 10 https://hypervision.art/news/jp/pfizers-lung-cancer-drug-trial-fails-to-boost #UnhingedWorld
That cursed thumbnail up top? Spat out by HyperVision AI in about 4 seconds. Go make your own monstrosity — ruin someone's feed today. 🔥